Arthritis Patients Are Being Denied Methotrexate Post-Roe. Are People With Cancer Next?
Methotrexate is an important therapy for cancer and some oncologists are concerned about the potential knock-on effect of the supreme court decision on patients.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma & Source Type: news
More News: Arthritis | Cancer | Cancer & Oncology | Legislation | Methotrexate | Pharmaceuticals | Rheumatology | Science